<DOC>
	<DOCNO>NCT00728546</DOCNO>
	<brief_summary>Apply information NAT2 genotyping re-challenge protocol INH titration patient anti-TB medication induce hepatitis .</brief_summary>
	<brief_title>NAT2 Re-challenge INH Patients With Hepatitis</brief_title>
	<detailed_description>adjust INH dose accord NAT2 genotyping serum concentration INH .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<criteria>Older 18 yearsold Taken INH 1 week Abnormal liver function Exclusion criterion : Rule INH induce liver abnormality Existing reason cause liver abnormality TBmedication Taking drug interact INH</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>tuberculosis</keyword>
	<keyword>isoniazid</keyword>
	<keyword>Arylamine N-acetyl transferase</keyword>
	<keyword>genotyping</keyword>
	<keyword>hepatotoxicity</keyword>
	<keyword>pharmacogenetics</keyword>
</DOC>